Phase II/pharmacodynamic trial of dose-intensive, weekly parenteral hydroxyurea and fluorouracil administered with interferon alfa-2a in patients with refractory malignancies of the gastrointestinal tract
Scott Wadler, Snehal Damle, Hilda Haynes, Ron Kaleya, Richard Schechner, Robert Berkenblit, Robert D. Ladner, Anthony Murgo
Dive into the research topics of 'Phase II/pharmacodynamic trial of dose-intensive, weekly parenteral hydroxyurea and fluorouracil administered with interferon alfa-2a in patients with refractory malignancies of the gastrointestinal tract'. Together they form a unique fingerprint.